MedPath

Calamine

Equaline 336.003/336AG Medicated Calamine Lotion

Approved
Approval ID

0bc1a9b4-1210-4d9a-bbd2-40e9225e86ea

Product Type

HUMAN OTC DRUG LABEL

Effective Date

Jun 2, 2025

Manufacturers
FDA

United Natural Foods, Inc. dba UNFI

DUNS: 943556183

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Calamine, Pramoxine HCl

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code41163-536
Application NumberM016
Product Classification
M
Marketing Category
C200263
G
Generic Name
Calamine, Pramoxine HCl
Product Specifications
Route of AdministrationTOPICAL
Effective DateJune 2, 2025
FDA Product Classification

INGREDIENTS (13)

ALCOHOLInactive
Code: 3K9958V90M
Classification: IACT
BENZYL ALCOHOLInactive
Code: LKG8494WBH
Classification: IACT
CAMPHOR (NATURAL)Inactive
Code: N20HL7Q941
Classification: IACT
HYPROMELLOSE, UNSPECIFIEDInactive
Code: 3NXW29V3WO
Classification: IACT
LAVENDER OILInactive
Code: ZBP1YXW0H8
Classification: IACT
PHENOXYETHANOLInactive
Code: HIE492ZZ3T
Classification: IACT
POLYSORBATE 80Inactive
Code: 6OZP39ZG8H
Classification: IACT
PROPYLENE GLYCOLInactive
Code: 6DC9Q167V3
Classification: IACT
ROSEMARY OILInactive
Code: 8LGU7VM393
Classification: IACT
WATERInactive
Code: 059QF0KO0R
Classification: IACT
XANTHAN GUMInactive
Code: TTV12P4NEE
Classification: IACT
FERRIC OXIDE REDActive
Quantity: 80 mg in 1 mL
Code: 1K09F3G675
Classification: ACTIB
PRAMOXINE HYDROCHLORIDEActive
Quantity: 10 mg in 1 mL
Code: 88AYB867L5
Classification: ACTIB

Drug Labeling Information

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

LOINC: 51945-4Updated: 6/2/2025

Principal display panel

Compare to Caladryl ®Lotion active ingredient*

NDC 41163-536-30

EQUALINE ®

medicated calamine lotion

external analgesic

skin protectant

drying action plus itch relief

6 FL OZ (177 mL)

image description

INDICATIONS & USAGE SECTION

LOINC: 34067-9Updated: 6/2/2025

Use

  • for the temporary relief of pain and itching associated with minor skin irritations and rashes due to poison ivy, poison oak, or poison sumac
  • dries the oozing and weeping of poison:
  • ivy
  • oak
  • sumac

ADVERSE REACTIONS SECTION

LOINC: 34084-4Updated: 6/2/2025

ADVERSE REACTION

DISTRIBUTED BY UNFI

PROVIDENCE, RI 02908 USA

855-423-2630

DOSAGE & ADMINISTRATION SECTION

LOINC: 34068-7Updated: 6/2/2025

Directions

  • shake well
  • before applying was affected are of skin

Adults and children 2 years of age and older - apply to affected area not more than 3 to 4 times daily

Children under 2 years of age - do not use, ask a doctor

OTC - STOP USE SECTION

LOINC: 50566-9Updated: 6/2/2025

Stop use and ask a doctor

  • condition worsens
  • symptoms last more than 7 days or clear up and occur again within a few days

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

LOINC: 50565-1Updated: 6/2/2025

Keep out of reach of children.

If swallowed, get medical help or contact a Poison Control Center right away.

OTC - ACTIVE INGREDIENT SECTION

LOINC: 55106-9Updated: 6/2/2025

Active ingredients

Calamine 8%

Pramoxine HCl 1%

OTC - PURPOSE SECTION

LOINC: 55105-1Updated: 6/2/2025

Purpose

Skin protectant

External analgesic

WARNINGS SECTION

LOINC: 34071-1Updated: 6/2/2025

Warnings

For external use only

OTC - WHEN USING SECTION

LOINC: 50567-7Updated: 6/2/2025

When using this product

  • do not get into eyes

SPL UNCLASSIFIED SECTION

LOINC: 42229-5Updated: 6/2/2025

Disclaimer

*This product is not manufactured or distributed by Bausch Health US, LLA, distributor of Caladryl Lotion Calamine Plus Itch Reliever.

INACTIVE INGREDIENT SECTION

LOINC: 51727-6Updated: 6/2/2025

Inactive ingredients

alcohol, benzyl alcohol, camphor, fragrance, hydroxypropyl methylcellulose, Lavandula angustifolia (lavender) oil, phenoxyethanol, polysorbate 80, propylene glycol, Rosmarinus officinalis (rosemary) leaf oil, water, xanthan gum

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Calamine - FDA Drug Approval Details